ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 639 filers reported holding ASTRAZENECA PLC in Q4 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $249,000 | -17.5% | 5,590 | -23.7% | 0.00% | -33.3% |
| Q2 2019 | $302,000 | +18.0% | 7,324 | +15.6% | 0.00% | 0.0% |
| Q1 2019 | $256,000 | +15.8% | 6,338 | +9.1% | 0.00% | +50.0% |
| Q4 2018 | $221,000 | -30.5% | 5,810 | -27.7% | 0.00% | -33.3% |
| Q3 2018 | $318,000 | +10.8% | 8,036 | -1.6% | 0.00% | 0.0% |
| Q2 2018 | $287,000 | +7.1% | 8,163 | +6.4% | 0.00% | 0.0% |
| Q1 2018 | $268,000 | +4.3% | 7,669 | +3.4% | 0.00% | +50.0% |
| Q4 2017 | $257,000 | +3.6% | 7,420 | +1.4% | 0.00% | 0.0% |
| Q3 2017 | $248,000 | -19.2% | 7,315 | -25.8% | 0.00% | -33.3% |
| Q1 2017 | $307,000 | +20.9% | 9,853 | +6.0% | 0.00% | +50.0% |
| Q4 2016 | $254,000 | -3.4% | 9,292 | +6.8% | 0.00% | 0.0% |
| Q2 2016 | $263,000 | -37.5% | 8,699 | -41.8% | 0.00% | -50.0% |
| Q1 2016 | $421,000 | – | 14,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |